Skip to content

Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)

Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031672
Enrollment
Unknown
Registered
2020-04-06
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the history of COVID-19 confirmed in accordance with the diagnosis and treatment plan of COVID-19(trial seventh edition); 2. Meet the discharge standards of COVID-19(trial seventh edition); 3. Meet the diagnosis standard of qi deficiency and phlegm stasis syndrome; 4. Patients aged 18-70 years old, 28 days after discharge, still have abnormal manifestations on lung CT; 5. Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with primary and secondary cardiovascular, cerebrovascular, renal, endocrine, neurological and blood system diseases, tumors and tuberculosis; 2. Patients who have participated in or are participating in other clinical trials within one month; 3. Patients with mental disorders who can not express their feelings; 4. There are other situations that are not suitable to be included in the study.

Design outcomes

Primary

MeasureTime frame
Lung CT Score;

Secondary

MeasureTime frame
COVID-19 symptom score;Integral evaluation of qi deficiency and phlegm stasis syndrome;Pulmonary function assessment;St George's respiratory questionnaire score;

Countries

China

Contacts

Public ContactYingshuai Li

Beijing University of Chinese Medicine

liyingshuai2013@163.com+86 13681410020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026